What question did this study set out to answer?

This research aims to explore discrepancies between patients' and doctors' symptom reports during chemotherapy.

March 1, 2026HETI Journal International Research and PracticeOpen Access

Patients’ daily reporting of symptoms via mobile application reveals a significant difference between patients’ perceptions and doctors’ interpretations

View Full Paper

Ask AI

Bookmark

Authors

Cohort study shows discrepancies in symptom reporting between patients and doctors, suggesting better patient experience evaluation is needed.

This research aims to explore discrepancies between patients' and doctors' symptom reports during chemotherapy.
Single-center prospective cohort study involving 46 patients on (neo)adjuvant chemotherapy for early breast cancer.
Patients used an Android-based mobile app to report symptoms daily.
Comparison of patients’ reports with doctor assessments and validated quality of life questionnaires.
Assessment of m-app usability and satisfaction among patients and doctors.
Patients reported almost twice as many symptoms via the m-app compared to doctors (75 vs 49).
Significantly higher frequency and intensity of symptoms reported by patients (p<0.001).
Fatigue, insomnia, and dry mouth were leading symptoms, often underreported by doctors.
Quality of life assessments showed worsening physical and cognitive functions after three months of treatment.
Both patients and doctors rated the m-app positively with an overall score of 4.5 out of 5.

GrašičKuhar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Cohort study shows discrepancies in symptom reporting between patients and doctors, suggesting better patient experience evaluation is needed.